Table 3 Descriptive statistics and proportion of sample with clinically elevated scores on self-reported questionnaires for participants and carer-reported measures with 95% confidence intervals. Cut scores used were taken from each scales’ published psychometric analysis were used to indicate percent of participants with elevated symptoms or scores warranting clinical attention (termed “clinically significant” within the table)

Post-Stroke Abilities

 Modified Rankin Scale Score^a

100

1.79 (1.27)

30 (28.6 [19.7 – 37.4])

 Barthel-3 Item Short Form Total^a

99

6.93 (1.58)

–

 Nottingham Extended ADL^a

100

47.77 (16.26)

–

Quality of Life

 SIS-Short Form Scaled Total^1a

102

72.66 (20.12)

–

 SIS-Long Form Stroke Recovery Score^b

88

71.91 (21.63)

–

 WHO-QoL–BREF Overall Score^b

83

7.22 (1.65)

–

 ICECAP-A Total^a

101

15.65 (2.90)

–

 EQ5D-5L Health Rating^a

99

68.61 (18.83)

–

Cognitive Ability

 CFQ Total^b

88

33.60 (17.93)

29 (32.2 [22.5 – 41.9])

 Cognitive Reserve Index^b

84

128.42 (19.68)

–

Emotional Distress

 HADS-Depression Total^a

98

4.97 (3.98)

23 (23.5 [15.1 – 31.9])

 HADS-Anxiety Total^a

98

5.23 (4.02)

22 (22.5 [14.2 – 30.7])

 GDS Total^a

101

4.22 (4.10)

34 (33.7 [24.4 – 42.9])

Extended Outcomes

 Apathy Evaluation Scale^a

101

32.36 (10.21)

41 (40.6 [31.0 – 50.2])

 Fatigue Severity Scale^a

101

35.56 (15.34)

52 (51.5 [41.7 – 61.2])

 Sleep Condition Indicator^a

100

23.29 (8.04)

21 (21.0 [13.0 – 28.9])

Carer Measures

 CSI Total Score^a

68

2.76 (3.12)

9 (13.2 [5.2 – 21.2])

 Informant-GDS Total^a

70

5.18 (4.30)

35 (50.0 [38.2 – 61.7])

 IQ-CODE^a

74

3.23 (0.63)

29 (39.2 [28.1 – 50.3])